A detailed history of Lantern Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lantern Wealth Advisors, LLC holds 1,069 shares of LLY stock, worth $960,068. This represents 0.58% of its overall portfolio holdings.

Number of Shares
1,069
Previous 1,070 0.09%
Holding current value
$960,068
Previous $624 Million 33.33%
% of portfolio
0.58%
Previous 0.49%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $592 - $792
-1 Reduced 0.09%
1,069 $832 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $561,953 - $662,469
1,070 New
1,070 $624 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lantern Wealth Advisors, LLC Portfolio

Follow Lantern Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantern Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantern Wealth Advisors, LLC with notifications on news.